Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,113
Closed -$475K 127
2021
Q2
$475K Sell
6,113
-293
-5% -$21.8K 0.11% 99
2021
Q1
$471K Hold
6,406
0.12% 97
2020
Q4
$500K Sell
6,406
-686
-10% -$52.5K 0.15% 91
2020
Q3
$561K Hold
7,092
0.19% 74
2020
Q2
$523K Hold
7,092
0.19% 75
2020
Q1
$521K Hold
7,092
0.22% 64
2019
Q4
$615K Hold
7,092
0.17% 67
2019
Q3
$570K Hold
7,092
0.16% 68
2019
Q2
$567K Sell
7,092
-194
-3% -$14.9K 0.16% 65
2019
Q1
$578K Sell
7,286
-104
-1% -$7.78K 0.17% 63
2018
Q4
$539K Sell
7,390
-361
-5% -$25.5K 0.17% 67
2018
Q3
$525K Hold
7,751
0.14% 76
2018
Q2
$449K Hold
7,751
0.11% 78
2018
Q1
$403K Hold
7,751
0.09% 85
2017
Q4
$416K Hold
7,751
0.09% 86
2017
Q3
$474K Buy
7,751
+40
+0.5% +$2.42K 0.11% 79
2017
Q2
$472K Hold
7,711
0.12% 76
2017
Q1
$468K Sell
7,711
-3,354
-30% -$203K 0.11% 75
2016
Q4
$622K Sell
11,065
-1,781
-14% -$104K 0.15% 69
2016
Q3
$765K Sell
12,846
-2,935
-19% -$172K 0.19% 66
2016
Q2
$867K Hold
15,781
0.21% 66
2016
Q1
$797K Sell
15,781
-45,357
-74% -$2.22M 0.2% 66
2015
Q4
$3.08M Buy
61,138
+46,403
+315% +$2.34M 0.8% 48
2015
Q3
$694K Hold
14,735
0.15% 70
2015
Q2
$800K Hold
14,735
0.13% 75
2015
Q1
$808K Hold
14,735
0.12% 74
2014
Q4
$798K Hold
14,735
0.14% 77
2014
Q3
$833K Sell
14,735
-109,532
-88% -$6.15M 0.11% 79
2014
Q2
$6.86M Sell
124,267
-1,886
-1% -$103K 1% 32
2014
Q1
$6.83M Sell
126,153
-4,716
-4% -$244K 1.14% 36
2013
Q4
$6.25M Sell
130,869
-3,617
-3% -$165K 1% 39
2013
Q3
$6.11M Buy
134,486
+1,709
+1% +$78K 1.07% 37
2013
Q2
$5.88M Buy
+132,777
New +$5.93M 1.08% 33

Other funds holding MRK

Hourglass Capital's MRK Position: Q3 2021 in Review

Hourglass Capital sold out of Merck (MRK) in Q3 2021, closing a stake of 6,113 shares — an estimated $475K sold.

Hourglass Capital first reported a position in MRK in Q2 2013 and held it in 33 quarters. The position peaked at $6.86M in Q2 2014. 2,647 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

  • Hourglass Capital reported no remaining Merck position as of Q3 2021 after selling out during the quarter.
  • Hourglass Capital sold 6,113 Merck shares in Q3 2021, an estimated $475K.
  • Hourglass Capital first reported a position in Merck in Q2 2013 and held it in 33 quarters.
  • Hourglass Capital's Merck position peaked at $6.86M in Q2 2014.
  • 2,647 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on Hourglass Capital's 13F filing for Q3 2021, filed 12 Nov 2021.